199 related articles for article (PubMed ID: 19572550)
1. Flaviviral protease inhibitors identified by fragment-based library docking into a structure generated by molecular dynamics.
Ekonomiuk D; Su XC; Ozawa K; Bodenreider C; Lim SP; Otting G; Huang D; Caflisch A
J Med Chem; 2009 Aug; 52(15):4860-8. PubMed ID: 19572550
[TBL] [Abstract][Full Text] [Related]
2. High-throughput virtual screening lead to discovery of non-peptidic inhibitors of West Nile virus NS3 protease.
Huang D
Methods Mol Biol; 2012; 819():615-23. PubMed ID: 22183561
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U
Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006
[TBL] [Abstract][Full Text] [Related]
4. Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation.
Robin G; Chappell K; Stoermer MJ; Hu SH; Young PR; Fairlie DP; Martin JL
J Mol Biol; 2009 Feb; 385(5):1568-77. PubMed ID: 19059417
[TBL] [Abstract][Full Text] [Related]
5. NMR study of complexes between low molecular mass inhibitors and the West Nile virus NS2B-NS3 protease.
Su XC; Ozawa K; Yagi H; Lim SP; Wen D; Ekonomiuk D; Huang D; Keller TH; Sonntag S; Caflisch A; Vasudevan SG; Otting G
FEBS J; 2009 Aug; 276(15):4244-55. PubMed ID: 19583774
[TBL] [Abstract][Full Text] [Related]
6. Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.
Stoermer MJ; Chappell KJ; Liebscher S; Jensen CM; Gan CH; Gupta PK; Xu WJ; Young PR; Fairlie DP
J Med Chem; 2008 Sep; 51(18):5714-21. PubMed ID: 18729351
[TBL] [Abstract][Full Text] [Related]
7. Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors.
Yin Z; Patel SJ; Wang WL; Chan WL; Ranga Rao KR; Wang G; Ngew X; Patel V; Beer D; Knox JE; Ma NL; Ehrhardt C; Lim SP; Vasudevan SG; Keller TH
Bioorg Med Chem Lett; 2006 Jan; 16(1):40-3. PubMed ID: 16246563
[TBL] [Abstract][Full Text] [Related]
8. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
Zhou H; Singh NJ; Kim KS
Proteins; 2006 Nov; 65(3):692-701. PubMed ID: 16972281
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the West Nile virus protease substrate specificity and inhibitors.
Mueller NH; Yon C; Ganesh VK; Padmanabhan R
Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
[TBL] [Abstract][Full Text] [Related]
10. Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites.
Chanprapaph S; Saparpakorn P; Sangma C; Niyomrattanakit P; Hannongbua S; Angsuthanasombat C; Katzenmeier G
Biochem Biophys Res Commun; 2005 May; 330(4):1237-46. PubMed ID: 15823576
[TBL] [Abstract][Full Text] [Related]
11. Exploring the binding of peptidic West Nile virus NS2B-NS3 protease inhibitors by NMR.
Kang C; Gayen S; Wang W; Severin R; Chen AS; Lim HA; Chia CS; Schüller A; Doan DN; Poulsen A; Hill J; Vasudevan SG; Keller TH
Antiviral Res; 2013 Feb; 97(2):137-44. PubMed ID: 23211132
[TBL] [Abstract][Full Text] [Related]
12. Library screening by fragment-based docking.
Huang D; Caflisch A
J Mol Recognit; 2010; 23(2):183-93. PubMed ID: 19718684
[TBL] [Abstract][Full Text] [Related]
13. Peptide inhibitors of Dengue virus NS3 protease. Part 1: Warhead.
Yin Z; Patel SJ; Wang WL; Wang G; Chan WL; Rao KR; Alam J; Jeyaraj DA; Ngew X; Patel V; Beer D; Lim SP; Vasudevan SG; Keller TH
Bioorg Med Chem Lett; 2006 Jan; 16(1):36-9. PubMed ID: 16246553
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 2-{6-[2-(5-phenyl-4H-{1,2,4]triazol-3-ylsulfanyl)acetylamino]benzothiazol-2-ylsulfanyl}acetamide scaffold.
Samanta S; Lim TL; Lam Y
ChemMedChem; 2013 Jun; 8(6):994-1001. PubMed ID: 23619931
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of a hydrogen bonding network from West Nile virus protease onto Dengue-2 protease improves catalytic efficiency and sheds light on substrate specificity.
Doan DN; Li KQ; Basavannacharya C; Vasudevan SG; Madhusudhan MS
Protein Eng Des Sel; 2012 Dec; 25(12):843-50. PubMed ID: 22972763
[TBL] [Abstract][Full Text] [Related]
16. Phosphonate inhibitors of West Nile virus NS2B/NS3 protease.
Skoreński M; Milewska A; Pyrć K; Sieńczyk M; Oleksyszyn J
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):8-14. PubMed ID: 30362835
[TBL] [Abstract][Full Text] [Related]
17. Binding of low molecular weight inhibitors promotes large conformational changes in the dengue virus NS2B-NS3 protease: fold analysis by pseudocontact shifts.
de la Cruz L; Nguyen TH; Ozawa K; Shin J; Graham B; Huber T; Otting G
J Am Chem Soc; 2011 Nov; 133(47):19205-15. PubMed ID: 22007671
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ
J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519
[TBL] [Abstract][Full Text] [Related]
19. West Nile Virus (WNV) protease and membrane interactions revealed by NMR spectroscopy.
Gayen S; Chen AS; Huang Q; Kang C
Biochem Biophys Res Commun; 2012 Jul; 423(4):799-804. PubMed ID: 22713461
[TBL] [Abstract][Full Text] [Related]
20. Novel agmatine and agmatine-like peptidomimetic inhibitors of the West Nile virus NS2B/NS3 serine protease.
Lim HA; Joy J; Hill J; San Brian Chia C
Eur J Med Chem; 2011 Jul; 46(7):3130-4. PubMed ID: 21565434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]